dimyristoylphosphatidylcholine has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bean, PA; Bulanadi, JC; de Campo, L; Gong, X; Julovi, SM; Moghaddam, MJ; Smith, RC; Xue, A | 1 |
| Ichihara, H; Matsumoto, Y; Motomura, M | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Cancer of Pancreas
| Article | Year |
|---|---|
Biomimetic Gemcitabine-Lipid Prodrug Nanoparticles for Pancreatic Cancer.
Topics: Animals; Biomimetic Materials; Carboxylesterase; Cell Line, Tumor; Deoxycytidine; Dimyristoylphosphatidylcholine; Gemcitabine; Liposomes; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Pancreas; Pancreatic Neoplasms; Prodrugs; Swine | 2020 |
Therapeutic effects and anti-metastasis effects of cationic liposomes against pancreatic cancer metastasis in vitro and in vivo.
Topics: Animals; Cations; Cell Line, Tumor; Cell Movement; Dimyristoylphosphatidylcholine; Ethanolamines; Ethylamines; Humans; Liposomes; Mice, Inbred BALB C; Neoplasm Invasiveness; Pancreatic Neoplasms | 2019 |